https://www.aravax.com.au/our-team 0.5 2019-05-06 monthly https://www.aravax.com.au/about-us 0.5 2019-05-06 monthly https://www.aravax.com.au/our-product 0.5 2019-05-06 monthly https://www.aravax.com.au/single-post/2018/01/29/Collaborator-of-Aravax-the-Benaroya-Research-Institute-receives-5-million-National-Institute-of-Health-grant-to-investigate-immune-mechanisms-of-PVX108 0.5 2018-07-25 monthly https://www.aravax.com.au/board-of-directors 0.5 2019-05-06 monthly https://www.aravax.com.au/single-post/2018/01/13/Aravax-presents-encouraging-preliminary-Phase-I-safety-data-at-the-worlds%E2%80%99-first-Gordon-Research-Conference-on-Food-Allergies-in-California 0.5 2018-07-03 monthly https://www.aravax.com.au/ 1.0 2019-05-06 monthly https://www.aravax.com.au/management-test 0.5 2019-05-06 monthly https://www.aravax.com.au/single-post/2018/01/09/Aravax-forms-Scientific-Advisory-Board 0.5 2018-07-03 monthly https://www.aravax.com.au/news 0.5 2019-05-06 monthly https://www.aravax.com.au/single-post/2019/05/29/Aravax-to-Present-Additional-PVX108-Phase-1-Clinical-Trial-Safety-Results-at-EAACI-2019-Annual-Meeting 0.5 2019-05-29 monthly https://www.aravax.com.au/product-development 0.5 2019-05-06 monthly https://www.aravax.com.au/scientific-advisory-board 0.5 2019-05-06 monthly https://www.aravax.com.au/contact 0.5 2019-05-06 monthly https://www.aravax.com.au/single-post/2017/01/20/Aravax-forms-research-collaboration-with-Benaroya-Research-Institute 0.5 2018-07-03 monthly https://www.aravax.com.au/single-post/2018/07/26/Aravax-receives-19-million-investment-tranche-from-the-Medical-Research-Commercialisation-Fund-to-complete-Phase-1-and-prepare-for-Phase-2 0.5 2018-07-25 monthly https://www.aravax.com.au/single-post/2017/05/16/Australian-Biotech-company-launches-clinical-trials-for-revolutionary-peanut-allergy-treatment 0.5 2018-07-03 monthly https://www.aravax.com.au/management 0.5 2019-05-06 monthly https://www.aravax.com.au/clinical-trial 0.5 2019-05-06 monthly https://www.aravax.com.au/single-post/2017/11/17/Aravax-forms-research-collaboration-with-Stanford-University 0.5 2018-07-03 monthly https://www.aravax.com.au/single-post/2019/06/04/Aravax-Presents-Additional-Positive-PVX108-Phase-1-Clinical-Trial-Safety-Results-at-EAACI-2019-Annual-Meeting 0.5 2019-06-04 monthly https://www.aravax.com.au/single-post/2019/02/27/Australian-peanut-therapy-developer-Aravax-reveals-positive-Phase-I-trial-results-at-world-leading-allergy-conference 0.5 2019-05-29 monthly https://www.aravax.com.au/about-us-1 0.5 2019-05-06 monthly https://www.aravax.com.au/single-post/2019/02/15/Aravax-to-Present-PVX108-Phase-1-Clinical-Trial-Results-at-AAAAI-2019-Annual-Meeting 0.5 2019-02-24 monthly https://www.aravax.com.au/single-post/2015/11/23/9-million-cash-injection-for-two-victorian-biotech-companies 0.5 2018-07-03 monthly